Canadian Pacific Railway Ltd. is reporting flat profits despite record third-quarter revenues.
Ford cuts guidance on higher costs from incentives, warranties
Ford Motor Co., struggling to roll out its redesigned Explorer sport-utility vehicle, cut its full-year forecast by US$500 million, in a sign an US$11 billion restructuring by Chief Executive Officer Jim Hackett’s will take more time before a promised payoff.
Rogers falls most since January 2016 after cutting forecast
Rogers cited accelerated demand for new unlimited mobile data plans for cutting annual forecasts on key financial measures Wednesday in its earnings statement.
Popeyes will hire more staff to deal with return of hit sandwich
The Popeyes restaurant chain is bringing back its overwhelmingly popular chicken sandwich, but this time it’s calling in reinforcements.
GFL seeks to raise US$2.1B in biggest Canada IPO since 2004
The Vaughan, Ontario-based company and some shareholders plan to sell 87.6 million shares at US$20 to US$24 each.
Bill to tax vaping like tobacco products clears House committee
The House Ways and Means Committee approved legislation that would tax e-cigarettes, such as vaping devices, the same as tobacco products.
Beyond Meat falls below US$100 as investors fear earnings deja vu
The plant-based meat maker has been on the decline since late July, when some holders, including CEO Ethan Brown took advantage of an early secondary offering to sell shares a steep discount.
Eli Lilly CEO says drugmaker won’t rehash old Alzheimer's data
Digging through old data to salvage a seemingly failed Alzheimer’s drug paid off big time for Biogen Inc., but at least one of its rivals has no plans to follow suit.
Boeing climbs after mapping 36% output jump in 737 Max next year
Boeing is trying to work through one of the biggest crises in its 103-year history after two deadly Max crashes killed 346 people in a five-month span and prompted a global flying ban in March.
Impossible Foods seeks to sell plant-based burgers in Europe
Genetically-modified foods and labelling are tightly regulated in the EU, unlike the U.S., which could mean approval could take time.